Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Merck
Colorcon
Boehringer Ingelheim
Medtronic

Last Updated: September 26, 2022

GLUCOTROL XL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Glucotrol Xl, and what generic alternatives are available?

Glucotrol Xl is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in GLUCOTROL XL is glipizide. There are eighteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the glipizide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Glucotrol Xl

A generic version of GLUCOTROL XL was approved as glipizide by AUROBINDO PHARMA USA on May 10th, 1994.

  Sign up for a Free Trial

Drug patent expirations by year for GLUCOTROL XL
Drug Prices for GLUCOTROL XL

See drug prices for GLUCOTROL XL

Drug Sales Revenue Trends for GLUCOTROL XL

See drug sales revenues for GLUCOTROL XL

Recent Clinical Trials for GLUCOTROL XL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Baylor College of MedicinePhase 4
NovartisPhase 2
Chinese Academy of SciencesN/A

See all GLUCOTROL XL clinical trials

Pharmacology for GLUCOTROL XL
Drug Class Sulfonylurea

US Patents and Regulatory Information for GLUCOTROL XL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-003 Aug 10, 1999 AB RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994 AB RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-002 Apr 26, 1994 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for GLUCOTROL XL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-002 Apr 26, 1994 See Plans and Pricing See Plans and Pricing
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994 See Plans and Pricing See Plans and Pricing
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-003 Aug 10, 1999 See Plans and Pricing See Plans and Pricing
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994 See Plans and Pricing See Plans and Pricing
Pfizer GLUCOTROL XL glipizide TABLET, EXTENDED RELEASE;ORAL 020329-001 Apr 26, 1994 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for GLUCOTROL XL

See the table below for patents covering GLUCOTROL XL around the world.

Country Patent Number Title Estimated Expiration
Japan S5793065 PERMEATION APPARATUS HAVING HYDROGEL DRIVE MEMBER See Plans and Pricing
Mexico 163518 MEJORAS EN UN DISPOSITIVO OSMOTICO CON DOBLE ACTIVIDAD TERMODINAMICA PARA SUMINISTRAR A UN REGIMEN CONTROLADO UN AGENTE BENEFICO See Plans and Pricing
Norway 920740 See Plans and Pricing
Japan H05500222 See Plans and Pricing
Netherlands 8401470 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
McKesson
Mallinckrodt
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.